您的购物车当前为空
别名 LY2140023
LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist.

LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | 待询 | 3-6月 | |
| 50 mg | 待询 | 3-6月 | |
| 100 mg | 待询 | 3-6月 |
| 产品描述 | LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist. |
| 体内活性 | LY2140023 (orally;?3, 10, and 300 mg/kg;?once daily for 7 days) dose-dependent increases the levels of the dopamine metabolites dihydroxyphenylacetic acid and homovanillic acid (HVA)[1]. |
| 别名 | LY2140023 |
| 分子量 | 366.41 |
| 分子式 | C12H18N2O7S2 |
| CAS No. | 635318-55-7 |
| Smiles | N(C([C@H](CCSC)N)=O)[C@]1(C(O)=O)[C@]2([C@]([C@@H]2C(O)=O)(S(=O)(=O)C1)[H])[H] |
| 密度 | 1.31g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多